Intellia Therapeutics Inc buy BMO Capital Markets
Start price
13.03.23
/
50%
€36.37
Target price
13.03.24
-
Performance (%)
-27.88%
End price
14.03.24
€26.23
Summary
This prediction ended on 14.03.24 with a price of €26.23. The prediction for Intellia Therapeutics Inc disappointed with a performance of -27.88%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | -3.634% | -3.634% | -1.932% |
| iShares Core DAX® | 0.463% | -1.530% | 9.993% |
| iShares Nasdaq 100 | -1.792% | -5.385% | -0.879% |
| iShares Nikkei 225® | 5.124% | 8.053% | 30.035% |
| iShares S&P 500 | -1.760% | -3.821% | -0.209% |
Comments by BMO_Capital_Markets for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Stopped prediction by BMO_Capital_Markets for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.22
10.01.25
10.01.25
€48.67
10.01.26
10.01.26
-11.94%
11.01.26
11.01.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.72
10.05.24
10.05.24
€64.98
10.05.25
10.05.25
-67.39%
11.05.25
11.05.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.58
10.11.23
10.11.23
€58.01
10.11.24
10.11.24
-30.16%
11.11.24
11.11.24